60
L. Roubalov aꢀ et al. / Chemico-Biological Interactions 260 (2016) 58e66
benzopyran-4-one),
methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole),
1,9-pyrazoloanthrone), dimethyl sulfoxide (DMSO) and solvents
for HPLC were purchased from Sigma-Aldrich.
SB203580
(4-(4-fluorophenyl)-2-(4-
TaqMan Gene Expression Assays, consisting of specific primers and
FAM dye-labeled TaqMan minor groove binder probes (Applied
SP600125
(
Biosystems). The assay ID was Mm00516005_m1 for Hmox1 and
ꢀ
Mm99999915_g1 for Gapdh. Amplification conditions were 50
C
ꢀ
ꢀ
for 2 min, 95 C for 10 min, followed by 40 cycles at 95 C for 15 s
ꢀ
2.4. Cell cultures and treatments
and 60 C for 1 min. Crossing point values, equivalent to C
T
, were
determined using second derivative maximum analysis. Relative
The stable human mammary AREc32 reporter cell line [21] was
cultured in Dulbecco's modified Eagle's medium (DMEM; No.
1966, Gibco, Grand Island, NY, USA) supplemented with 2 mM
changes in gene expression were calculated by the comparative C
T
ꢂ
DDC
T
method using the 2
Gapdh mRNA levels.
equation with results normalized to
4
glutamine and 10% fetal bovine serum (FBS). The murine macro-
phage RAW264.7 cell line (No. 91062702, ECACC, Salisbury, UK) was
cultured in DMEM (D5796, Sigma) supplemented with 100 U/mL
2.8. Western blot analysis
5
penicillin, 100
atoma Hepa1c1c7 cell line (No. 95090613, ECACC) was cultured in
Minimum essential medium (M0894, Sigma) supplemented with
mg/mL streptomycin and 10% FBS. The murine hep-
After the treatment of RAW264.7 cells (8 ꢁ 10 cells/well in a 6-
5
well plate) or Hepa1c1c7 cells (4 ꢁ 10 cells/well in a 6-well plate),
a
total cellular extracts were prepared as described previously [11].
Aliquots containing an equal amount of protein were subjected to
electrophoresis through 4e12% sodium dodecyl sulfate-
polyacrylamide gel, proteins were transferred to polyvinylidene
difluoride membrane by electroblotting, and the membranes were
probed with appropriate primary antibodies. Rabbit polyclonal
heme oxygenase-1 (sc-10789), rabbit polyclonal Nrf2 (sc-722), goat
polyclonal Keap1 (sc-15246) and goat polyclonal actin (sc-1616)
antibodies were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Antibodies against NQO1, GCLC and GCLM were
kindly provided by Dr. John D. Hayes (University of Dundee, Dun-
dee, UK). Primary antibodies were visualized with rabbit anti-goat
or goat anti-rabbit horseradish peroxidase-conjugated secondary
antibodies using a chemiluminescent reaction.
2
.2 g/L NaHCO
3
and 10% heat- and charcoal-treated FBS. Cells were
ꢀ
maintained at 37 C in a humidified atmosphere containing 5% CO
2
.
For experiments, cells were seeded into multiwell plates in serum-
containing medium. Experiments on AREc32 and Hepa1c1c7 cells
were performed after 24 h of stabilization in fresh serum-
containing medium. For RAW264.7 cells, the culture medium was
replaced with serum-free medium after 8 h of stabilization, and
following overnight incubation the experiments were performed in
fresh serum-free conditions. Cells were treated with the tested
compounds (in 0.1% (v/v) DMSO) and negative controls were
treated with 0.1% DMSO alone.
2.5. Cell viability assay
5
RAW264.7 cells (1.7 ꢁ 10 cells/well in a 24-well plate) and
2.9. HPLC/MS analysis of biotransformation products
4
Hepa1c1c7 cells (1 ꢁ 10 cells/well in a 96-well plate) were treated
for 6 or 48 h, respectively, with 0.1% DMSO (control), 1.5% (v/v)
Triton X-100 (positive control) or with the tested compounds. After
treatment, the cell viability was determined using the MTT reduc-
tion assay. Cells were washed with phosphate-buffered saline (PBS)
5
RAW264.7 cells (8 ꢁ 10 cells/well in a 6-well plate) were
incubated for 0e6 h with 15 mM 7-O-galloylquercetin. After incu-
bation, cells were scraped from the plates, collected by gentle
centrifugation, washed twice with PBS, resuspended in 0.4 mL of
methanol containing 5% (v/v) acetic acid, and sonicated 10 times at
50% amplitude with a cycle set at 0.5 s using an Ultrasonic Processor
UP200s equipped with a Sonotrode Microtip S2 sonicator probe
(Hielscher, Teltow, Germany). Afterwards, the cell lysates were
centrifuged for 2 min at 14 000ꢁ g at room temperature and the
supernatants were analyzed by HPLC/MS. Aliquots of culture me-
dium were diluted (1:1, v/v) in methanol containing 5% (v/v) acetic
acid, centrifuged for 2 min at 14 000ꢁ g and the supernatants were
analyzed by HPLC/MS. The chromatographic separation was per-
formed in an Agilent Zorbax Eclipse XDB-phenyl column
ꢀ
and incubated for 2 h at 37 C in fresh serum-free medium con-
taining
0.5
mg/mL
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). After this, the medium was
removed and formazan produced by active mitochondria was dis-
solved in DMSO. The absorbance at 540 nm was measured on a
spectrophotometric plate reader and used to calculate relative cell
viability, where cells treated with DMSO alone represented 100%
viability.
2
.6. Gene reporter assay
(150 mm ꢁ 2.1 mm i.d., 5
mm; Agilent Technologies, CA, USA) using
4
AREc32 cells were seeded into a 96-well plate at 1 ꢁ 10 cells/
an Acquity UPLC system (Waters, Milford, MA, USA) equipped with
a binary solvent manager, sample manager, column manager and
photodiode array detector. A Waters QqTof Premier Mass Spec-
trometer (Waters, Manchester, UK) was connected to the UPLC
system via an electrospray ionization (ESI) interface. Acquiring data
enabled the collection of intact precursor ions as well as fragment
ion information in an unbiased manner. Post-acquisition processing
of the data was performed using Metabolynx V4.1 software (Wa-
ters, Milford, MA, USA). For more details, see Ref. [22].
well. On the next day, cells were exposed for 24 h to the tested
ꢀ
compounds. Afterwards, the plate was frozen at ꢂ20 C for 24 h and
then the luciferase activity was measured on
a GloMax-
Multiþ microplate luminometer (Promega, Madison, WI, USA) us-
ing the Bright-Glo Luciferase Assay System (Promega). The lumi-
nescence values were normalized to the protein content of the cells
and used for calculation of fold changes versus the control.
2.7. Reverse transcription and quantitative real-time PCR
2
.10. NQO1 activity assay
5
After the treatment of RAW264.7 cells (8 ꢁ 10 cells/well in a 6-
4
well plate), total RNA was extracted using TRI Reagent Solution
Applied Biosystems, Foster City, CA, USA). RNA samples (2
reverse transcribed using a High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems) and real-time PCR was per-
a LightCycler 480 II system (Roche Diagnostics,
Mannheim, Germany) using TaqMan Universal PCR Master Mix and
After the treatment of Hepa1c1c7 cells (1 ꢁ 10 cells/well in a
(
mg) were
96-well plate), the activity of NQO1 was determined spectropho-
tometrically as described previously [23]. Cells were washed four
times with PBS and lysed with 75
digitonin, 2 mM EDTA, pH 7.8) by shaking on an orbital shaker for
20 min at room temperature. One part of the cell lysate (20 L) was
mL of digitonin solution (0.8 g/L
formed in
m